- Comment on:
-
Chem Biol. 2007 Dec;14(12):1347-56.
2-AG + 2 new players = forecast for therapeutic advances.
Graduate Program in Neurobiology and Behavior, University of Washington, Seattle, WA 98195, USA.
In this issue of Chemistry & Biology, Blankman et al. identify new enzymes hydrolyzing the endocannabionoid 2-arachidonoyl glycerol (2-AG), increasing the complexity of endocannabinoid signaling in the brain, but also pinpointing additional therapeutic targets.
PMID: 18096497 [PubMed - indexed for MEDLINE]